Gubra A/S (CPH:GUBRA)

Denmark flag Denmark · Delayed Price · Currency is DKK
372.80
-2.20 (-0.59%)
Mar 9, 2026, 9:38 AM CET
Market Cap6.12B -44.6%
Revenue (ttm)2.64B +892.2%
Net Income1.69B
EPS102.70
Shares Out16.33M
PE Ratio3.65
Forward PE156.25
Dividendn/a
Ex-Dividend Daten/a
Volume4,307
Average Volume38,355
Open366.20
Previous Close375.00
Day's Range361.80 - 380.00
52-Week Range318.40 - 571.00
Beta0.16
RSI43.83
Earnings DateFeb 27, 2026

About Gubra

Gubra A/S, a disease-agnostic techbio company, focuses on the peptide-based drug discovery and preclinical contract research services in Europe, North America, and internationally. It operates through three segments: Preclinical Contract Research (CRO), Biotech, and Gubra Green. The company offers preclinical contract research and development services within metabolic and fibrotic diseases for the pharmaceutical and biotechnology industry; and various services in vivo pharmacology, biomarker assays, bioinformatics, next gen sequencing, bioinfor... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2008
Employees 275
Stock Exchange Copenhagen Stock Exchange
Ticker Symbol GUBRA
Full Company Profile

Financial Performance

Financial Statements

News

Full Year 2025 Gubra A/S Earnings Call Transcript

Full Year 2025 Gubra A/S Earnings Call Transcript

9 days ago - GuruFocus